Literature DB >> 16409138

Molecular approaches in pediatric oncology.

Chand Khanna1, Lee J Helman.   

Abstract

The use of molecular approaches has become part of the standard of care in the management of pediatric cancer patients. Molecular approaches are now included in the initial diagnosis, definition of prognostically distinct patient subgroups, selection of patients for specific therapies, prediction of risk for toxicities to therapy, and monitoring of patients receiving both conventional and novel targeted therapies. This clinical application of molecular medicine has been based on a growing molecular understanding of cancer biology. Studies of pediatric cancers have contributed to this understanding in many ways. We present a model for understanding cancer biology, using specific examples taken from pediatric oncology, and then discuss the application of molecular techniques to the clinical management of pediatric cancer patients.

Entities:  

Mesh:

Year:  2006        PMID: 16409138     DOI: 10.1146/annurev.med.57.121304.131247

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  4 in total

1.  New chemotherapy strategies and biological agents in the treatment of childhood ependymoma.

Authors:  Karen D Wright; Amar Gajjar
Journal:  Childs Nerv Syst       Date:  2009-02-11       Impact factor: 1.475

2.  Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes.

Authors:  Sa Deepak; Kr Kottapalli; R Rakwal; G Oros; Ks Rangappa; H Iwahashi; Y Masuo; Gk Agrawal
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

Review 3.  Chemotherapy for malignant brain tumors of childhood.

Authors:  Nicholas G Gottardo; Amar Gajjar
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

4.  Enduring Cell Lines: Parents' Experiences of Postmortem Tumor Banking in Childhood Cancer.

Authors:  Nancy J Moules; Catherine M Laing; Wendy Pelletier; Gregory M T Guilcher; Jennifer A Chan
Journal:  J Fam Nurs       Date:  2021-04-15       Impact factor: 3.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.